omniture
Pin Therapeutics

Latest News

Pin Therapeutics Initiates First-Patient Dosing of CK1α Degrader PIN-5018 in Phase 1 Trial

Preclinical Results Demonstrate Complete Response and Tumor Regression in ACC PDX Models SEOUL, So...

2025-11-24 15:11 744